ICD-10-CM Code C54.1

Malignant neoplasm of endometrium

Version 2020 Billable Code Diagnoses For Females Only Neoplasm Malignant Primary

Valid for Submission

C54.1 is a billable code used to specify a medical diagnosis of malignant neoplasm of endometrium. The code is valid for the year 2020 for the submission of HIPAA-covered transactions. The ICD-10-CM code C54.1 might also be used to specify conditions or terms like adenocarcinoma of endometrium, adenosquamous cell carcinoma, carcinosarcoma of corpus uteri, carcinosarcoma of uterus, endometrial carcinoma, endometrial carcinosarcoma, etc

The code C54.1 is applicable to female patients only. It is clinically and virtually impossible to use this code on a non-female patient.

The following anatomical sites found in the Table of Neoplasms apply to this code given the correct histological behavior: endometrium (gland) (stroma) or stroma, endometrial or uterus, uteri, uterine endometrium .

ICD-10:C54.1
Short Description:Malignant neoplasm of endometrium
Long Description:Malignant neoplasm of endometrium

Index to Diseases and Injuries

The Index to Diseases and Injuries is an alphabetical listing of medical terms, with each term mapped to one or more ICD-10 code(s). The following references for the code C54.1 are found in the index:


Code Edits

The Medicare Code Editor (MCE) detects and reports errors in the coding of claims data. The following ICD-10 Code Edits are applicable to this code:

  • Diagnoses for females only - Medicare Code Editor detects inconsistencies between a patient’s sex and any diagnosis on the patient’s record, this code applies to FEMALES only .

Synonyms

The following clinical terms are approximate synonyms or lay terms that might be used to identify the correct diagnosis code:

  • Adenocarcinoma of endometrium
  • Adenosquamous cell carcinoma
  • Carcinosarcoma of corpus uteri
  • Carcinosarcoma of uterus
  • Endometrial carcinoma
  • Endometrial carcinosarcoma
  • Endometrial stromal sarcoma
  • Endometrial stromal tumor
  • FIGO EC stage I
  • FIGO EC stage I A
  • FIGO EC stage I B
  • FIGO EC stage II
  • FIGO EC stage III
  • FIGO EC stage IIIB
  • FIGO EC stage IIIC1
  • FIGO EC stage IIIC2
  • FIGO EC stage IV
  • FIGO EC stage IVA
  • FIGO EC stage IVB
  • High grade endometrial stromal sarcoma
  • International Federation of Gynecology and Obstetrics endometrial cancer stage IIIA
  • Low grade endometrial stromal sarcoma
  • Malignant neoplasm of endometrium of corpus uteri
  • Malignant tumor involving an organ by direct extension from endometrium
  • Malignant tumor involving an organ by separate metastasis from endometrium
  • Malignant tumor involving bladder by direct extension from endometrium
  • Malignant tumor involving bladder by separate metastasis from endometrium
  • Malignant tumor involving left fallopian tube by direct extension from endometrium
  • Malignant tumor involving left fallopian tube by separate metastasis from endometrium
  • Malignant tumor involving left ovary by direct extension from endometrium
  • Malignant tumor involving left ovary by separate metastasis from endometrium
  • Malignant tumor involving rectum by direct extension from endometrium
  • Malignant tumor involving rectum by separate metastasis from endometrium
  • Malignant tumor involving right fallopian tube by direct extension from endometrium
  • Malignant tumor involving right fallopian tube by separate metastasis from endometrium
  • Malignant tumor involving right ovary by direct extension from endometrium
  • Malignant tumor involving right ovary by separate metastasis from endometrium
  • Malignant tumor involving vagina by direct extension from endometrium
  • Malignant tumor involving vagina by separate metastasis from endometrium
  • Malignant tumor involving vulva by direct extension from endometrium
  • Malignant tumor involving vulva by separate metastasis from endometrium
  • Primary adenosquamous carcinoma of endometrium
  • Primary endometrioid carcinoma of endometrium of body of uterus
  • Primary malignant clear cell neoplasm of endometrium
  • Primary malignant mixed Mullerian neoplasm of endometrium
  • Primary malignant neoplasm of endometrium
  • Primary mixed adenocarcinoma of endometrium
  • Primary mucinous adenocarcinoma of endometrium
  • Primary papillary serous cystadenocarcinoma of endometrium
  • Primary serous adenocarcinoma of endometrium
  • Primary small cell carcinoma of endometrium
  • Primary squamous cell carcinoma of endometrium
  • Primary undifferentiated carcinoma of endometrium
  • pT1
  • pT1a
  • Sarcoma of endometrium
  • Secondary malignant neoplasm of left fallopian tube
  • Secondary malignant neoplasm of left ovary
  • Secondary malignant neoplasm of rectum
  • Secondary malignant neoplasm of right fallopian tube
  • Secondary malignant neoplasm of right ovary
  • Secondary malignant neoplasm of vagina
  • Secondary malignant neoplasm of vulva
  • Squamous cell carcinoma of corpus uteri
  • Squamous cell carcinoma of corpus uteri
  • T1 : Endometrial tumor confined to corpus uteri
  • T1a : Tumor limited to endometrium
  • T1b : Endometrial tumor invades up to or less than one half of the endometrium
  • T1c : Endometrial tumor invades to more than one half of the endometrium
  • T2 : Endometrial tumor invades cervix, but does not extend beyond uterus
  • T2a : Endometrial tumor with endocervical glandular involvement
  • T2b : Endometrial tumor with cervical stromal invasion
  • T3 and/or cancer cells in ascites or peritoneal washings
  • T3b
  • T4 : Endometrial tumor invades bladder mucosa and/or bowel mucosa
  • Undifferentiated carcinoma of corpus uteri

Diagnostic Related Groups

The ICD-10 code C54.1 is grouped in the following groups for version MS-DRG V37.0 What are Diagnostic Related Groups?
The Diagnostic Related Groups (DRGs) are a patient classification scheme which provides a means of relating the type of patients a hospital treats. The DRGs divides all possible principal diagnoses into mutually exclusive principal diagnosis areas referred to as Major Diagnostic Categories (MDC).
applicable from 10/01/2020 through 09/30/2020.

  • 736 - UTERINE AND ADNEXA PROCEDURES FOR OVARIAN OR ADNEXAL MALIGNANCY WITH MCC
  • 737 - UTERINE AND ADNEXA PROCEDURES FOR OVARIAN OR ADNEXAL MALIGNANCY WITH CC
  • 738 - UTERINE AND ADNEXA PROCEDURES FOR OVARIAN OR ADNEXAL MALIGNANCY WITHOUT CC/MCC
  • 739 - UTERINE, ADNEXA PROCEDURES FOR NON-OVARIAN AND NON-ADNEXAL MALIGNANCY WITH MCC
  • 740 - UTERINE, ADNEXA PROCEDURES FOR NON-OVARIAN AND NON-ADNEXAL MALIGNANCY WITH CC
  • 741 - UTERINE, ADNEXA PROCEDURES FOR NON-OVARIAN AND NON-ADNEXAL MALIGNANCY WITHOUT CC/MCC

Convert C54.1 to ICD-9

  • 182.0 - Malig neo corpus uteri (Approximate Flag)

Code Classification

  • Neoplasms (C00–D48)
    • Malignant neoplasms of female genital organs (C51-C58)
      • Malignant neoplasm of corpus uteri (C54)

Code History

  • FY 2016 - New Code, effective from 10/1/2015 through 9/30/2016
    (First year ICD-10-CM implemented into the HIPAA code set)
  • FY 2017 - No Change, effective from 10/1/2016 through 9/30/2017
  • FY 2018 - No Change, effective from 10/1/2017 through 9/30/2018
  • FY 2019 - No Change, effective from 10/1/2018 through 9/30/2019
  • FY 2020 - No Change, effective from 10/1/2019 through 9/30/2020

Table of Neoplasms

The code C54.1 is included in the table of neoplasms by anatomical site. For each site there are six possible code numbers according to whether the neoplasm in question is malignant, benign, in situ, of uncertain behavior, or of unspecified nature. The description of the neoplasm will often indicate which of the six columns is appropriate.

Where such descriptors are not present, the remainder of the Index should be consulted where guidance is given to the appropriate column for each morphological (histological) variety listed. However, the guidance in the Index can be overridden if one of the descriptors mentioned above is present.

Neoplasm, neoplastic Malignant
Primary
Malignant
Secondary
CaInSitu Benign Uncertain
Behavior
Unspecified
Behavior
»endometrium (gland) (stroma)
C54.1C79.82D07.0D26.1D39.0D49.59
»stroma, endometrial
C54.1C79.82D07.0D26.1D39.0D49.59
»uterus, uteri, uterine
  »endometrium
C54.1C79.82D07.0D26.1D39.0D49.59

Information for Patients


Uterine Cancer

The uterus, or womb, is the place where a baby grows when a women is pregnant. There are different types of uterine cancer. The most common type starts in the endometrium, the lining of the uterus. This type is also called endometrial cancer.

The symptoms of uterine cancer include

  • Abnormal vaginal bleeding or discharge
  • Trouble urinating
  • Pelvic pain
  • Pain during intercourse

Uterine cancer usually happens after menopause. It is more common in women who have obesity. You also have a higher risk if you took estrogen-only hormone replacement therapy (menopausal hormone therapy) for many years.

Tests to find uterine cancer include a pelvic exam, imaging tests, and a biopsy. The most common treatment is a hysterectomy, which is surgery to remove the uterus. Sometimes the surgery also removes the ovaries and fallopian tubes. Other treatments include hormone therapy, radiation therapy, and chemotherapy. Some women get more than one type of treatment.

NIH: National Cancer Institute


[Learn More]